The International Vaccine Institute (IVI), the only international governmental body headquartered in South Korea, will hold a special training to a group of professionals in clinical trials from several Asian countries at the Seoul Palace Hotel on Aug. 26.
The program, called Good Clinical Practice (GCP), is a part of the IVI´s Diseases of the Most Impoverished, or DOMI, a five-year project the IVI is carrying out with a $40 million grant from the Bill and Melinda Gates Foundation. DOMI is designed to improve children´s health in developing countries by distributing and developing new and more effective vaccines for cholera, typhoid and shigellosis.
The three-day training is co-sponsored by GlaxoSmithKline, a multinational pharmaceutical company. It will provide some 20 trainees, mostly medical doctors, from China, India, Indonesia, Pakistan and Vietnam, medical training on universal standard clinical trials needed for investigating typhoid fever in the DOMI program.
"This course nicely illustrates how IVI gives technical assistance to accelerate the introduction of new vaccines into developing countries," said John Clemens, director of the institute.
Located at Seoul National University campus, the IVI was firstly initiated in 1997 under the auspices of the United Nations Development Program (UNDP). A not-for-profit International Organization, the IVI was founded with the aim of improving the health of children in developing countries through the development, introduction and use of new and improved vaccines of public health importance.